The Dom34 antibody is a research tool designed to detect the Dom34 protein, a key component in mRNA quality control pathways. Dom34 is involved in no-go decay (NGD) and ribosome rescue mechanisms, functioning alongside Hbs1 and Rli1 to dissociate stalled ribosomes . While extensive studies have characterized Dom34’s biological roles, antibody-specific data remains limited. This article synthesizes available information on Dom34 antibody production, specificity, and applications, drawing from product specifications and research contexts.
The Dom34 antibody targets the Dom34 protein (UniProt ID: Q9USL5), a 390-amino-acid polypeptide in Schizosaccharomyces pombe (fission yeast). Recombinant Dom34 proteins used for antibody generation are typically expressed in yeast systems with His-tag conjugation for purification . The antibody’s epitope specificity is not explicitly detailed in public records, but its design likely targets conserved regions of Dom34 to ensure cross-reactivity with endogenous proteins in experimental systems.
ELISA (Enzyme-Linked Immunosorbent Assay):
The antibody is validated for use in ELISA protocols to quantify Dom34 protein levels in lysates or purified samples . Its high specificity (>90% purity) ensures minimal cross-reactivity with unrelated proteins.
Western Blotting:
While not explicitly cited, antibodies against Dom34 are likely compatible with Western blotting based on standard practices for similar yeast proteins. Optimization of blocking conditions and secondary antibody selection would be required .
Immunofluorescence Microscopy:
No direct evidence supports its use in imaging, but structural studies of Dom34 (e.g., cytosolic localization) suggest potential utility in subcellular localization studies .
While Dom34’s role in mRNA quality control is well-documented , antibody-specific studies remain sparse. Its utility in detecting Dom34 in translational regulation or antiviral pathways (e.g., RNase L interaction ) is inferred but unreported. Further validation in contexts like polysome profiling or co-immunoprecipitation with Hbs1/Rli1 complexes would enhance its research value .
KEGG: spo:SPCC18B5.06
STRING: 4896.SPCC18B5.06.1
Dom34 is a highly conserved protein that participates in multiple RNA quality control pathways. Originally identified for its role in No-Go Decay (NGD), Dom34 forms a complex with Hbs1 that resembles the translation termination factors eRF1 and eRF3. This complex recognizes and resolves stalled ribosomes on aberrant mRNAs . Beyond quality control, Dom34 has been implicated in:
Resolution of ribosomes stalled due to structural obstacles or tRNA deficiency
Dissociation of vacant 80S ribosomes, particularly during stress recovery
Surveillance of non-functional 18S rRNA in immature 40S subunits
Antiviral defense through the OAS/RNase L pathway
Translational regulation of specific mRNAs, including those encoding protein O-mannosyltransferases
Dom34 appears to function as a general ribosome recycling factor that prevents sequestration of translation machinery, particularly when cells are under stress or recovering from stress conditions .
Dom34 binds directly to the A-site of ribosomes, partially mimicking a tRNA molecule. Cryo-electron microscopy analysis reveals that Dom34 loosens mRNA-ribosome interactions when the ribosome has stalled due to strong RNA structures . This structural interaction is crucial for its function in resolving stalled translation complexes.
In biochemical assays, Dom34 (together with Hbs1 and the ATPase Rli1/ABCE1) can cause:
Release of peptidyl-tRNA from stalled ribosomes
Separation of 40S and 60S ribosomal subunits
Recycling of translation components for new rounds of protein synthesis
Importantly, Dom34 recognizes ribosomes regardless of whether they are stalled at the 3' end of an mRNA or in the middle of a transcript, making it distinct from canonical termination factors .
Cells deficient in Dom34 exhibit several characteristic phenotypes that provide insight into its cellular functions:
Elevated 80S ribosome peaks in polysome profiles, reflecting accumulation of inactive ribosomes
Reduced translation efficiency, particularly under stress conditions
Impaired recovery of translation after glucose starvation or other stresses
Synthetic growth defects when combined with mutations affecting 40S ribosomal subunits
Increased half-life of aberrant mRNAs that would normally trigger No-Go Decay
Enhanced viral RNA stability and increased viral replication for certain RNA viruses
Interestingly, Dom34 single mutants often show minimal growth defects under standard laboratory conditions, but deficiencies become apparent under stress or when combined with mutations affecting ribosome biogenesis or function .
Dom34 has been identified as a novel restriction factor for positive-sense single-stranded RNA viruses through the OAS/RNase L pathway. This represents a previously uncharacterized function that links RNA quality control to innate immunity .
Mechanistically, Dom34 directly binds to RNase L to form a surveillance complex that recognizes and eliminates exogenous viral RNA in a translation-dependent manner. Downregulation of either Dom34 or RNase L increases viral replication and extends the half-life of viral RNA .
The process appears to work as follows:
Viral infection activates OAS3, which synthesizes 2'-5'-oligoadenylates (2-5A)
2-5A converts latent RNase L to an active dimeric form
Activated RNase L associates with Dom34 to form a surveillance complex
This complex selectively localizes to ribosomes translating viral RNA
The viral RNA is then degraded, limiting viral replication
Remarkably, the Dom34-RNase L complex appears to detect the "exogenous nature" of the RNA rather than specific sequences, providing a general mechanism for distinguishing self from non-self RNA during infection .
The Dom34-Hbs1 complex, together with the ATPase Rli1 (ABCE1), actively dissociates inactive 80S ribosomes that accumulate under stress conditions. This process is critical for translational recovery after stress and represents a novel level of translational control .
In vitro studies demonstrate that:
Dom34-Hbs1 can split vacant 80S ribosomes into 40S and 60S subunits
This activity is enhanced by Rli1 and requires ATP hydrolysis
The process is more efficient with ribosomes lacking bound mRNA or tRNA
In vivo evidence shows that:
Cells lacking Dom34 and Hbs1 recover more slowly from glucose starvation
This recovery defect correlates with delayed dissociation of inactive ribosomes
The phenotype can be suppressed by deletion of Stm1, a protein that stabilizes inactive ribosomes
Even under non-stress conditions, Dom34-Hbs1 appears to promote translation by maintaining a pool of ribosomal subunits available for initiation
This mechanism explains why Dom34 is particularly important in cells with reduced 40S ribosomal subunits – without Dom34-mediated recycling, the limited pool of 40S subunits becomes sequestered in inactive 80S complexes, exacerbating the translation deficiency .
An unexpected role for Dom34 has been discovered in regulating protein O-mannosylation, particularly during glycostress. Dom34 upregulates the translation of several protein O-mannosyltransferase (PMT) isoform transcripts by binding to their 5'-UTRs and activating translational initiation .
This function appears distinct from Dom34's role in ribosome recycling and no-go decay:
Dom34 overexpression increases Pmt1 protein levels approximately 1.78-fold
Dom34 binds to the 5'-UTR of PMT transcripts to enhance translation
A point mutation (E21A) that affects Dom34's putative RNase activity eliminates this translational enhancement
The combination of transcriptional and Dom34-mediated translational upregulation optimizes fungal cell recovery and survival during glycostress
This represents a novel mode of action for Dom34, suggesting it may have a preferred class of target transcripts for its translational activities beyond its general role in ribosome recycling.
When investigating Dom34's interactions with protein partners like RNase L or Hbs1, researchers typically employ several complementary approaches:
Co-immunoprecipitation (Co-IP): Using anti-Dom34 antibodies to pull down protein complexes, followed by western blotting for suspected binding partners. This has successfully demonstrated direct binding between Dom34 and RNase L .
Pull-down assays with recombinant proteins: For example, GST-tagged Dom34 can be used to pull down potential binding partners from cell lysates, confirming direct physical interactions.
Yeast two-hybrid screening: Particularly useful for identifying novel interaction partners of Dom34 in an unbiased manner.
Proximity labeling approaches: BioID or APEX2 fusions with Dom34 can identify proximal proteins in living cells, capturing even transient interactions.
When designing interaction studies, researchers should consider using RNase treatment of samples to distinguish RNA-dependent from direct protein-protein interactions, as Dom34 functions in ribonucleoprotein complexes.
Based on published research, several experimental systems have proven effective:
Cell culture infection models: Human cell lines with CRISPR-mediated knockout or siRNA knockdown of Dom34/Pelota, followed by viral challenge. Measurements typically include:
Viral titers by plaque assay
Viral RNA levels by qRT-PCR
Viral protein expression by western blotting
Cell viability assessments
Biochemical reconstitution: In vitro systems containing purified components of the OAS/RNase L pathway along with Dom34 and model viral RNAs can demonstrate direct effects on RNA stability.
Ribosome profiling: This technique has been invaluable in identifying translating ribosomes on viral RNA and how they are affected by Dom34-RNase L surveillance.
When designing such experiments, it's critical to include appropriate controls:
Dom34 rescue experiments to confirm specificity
RNase L-deficient cells as a positive control
Measurement of both viral RNA stability and viral replication
Dom34 participates in multiple cellular processes, making it challenging to attribute phenotypes to specific functions. The following methodological approaches help discriminate between different roles:
| Approach | Description | Distinguishes |
|---|---|---|
| Dom34 domain mutants | Testing specific mutations that affect particular functions | Structure-function relationships |
| Ribosome association assays | Examining Dom34 association with different ribosomal complexes | No-go decay vs. vacant ribosome recycling |
| Translation-specific inhibitors | Using drugs like cycloheximide or harringtonine | Translation-dependent vs. independent functions |
| Stress-recovery assays | Measuring translation reinitiation after glucose starvation | Stress response vs. basal functions |
| Viral RNA vs. cellular RNA half-life | Comparing stability of different RNA populations | Antiviral vs. RNA quality control functions |
Researchers should employ multiple approaches when investigating Dom34 functions, as different cellular contexts may reveal distinct aspects of its activity. Point mutations in Dom34 can also help separate its functions – for example, the E21A mutation specifically affects its role in translational enhancement of PMT transcripts .
When working with Dom34 antibodies for applications like western blotting, immunoprecipitation, or immunofluorescence, researchers should consider:
Antibody specificity: Validate antibodies using Dom34/Pelota knockout or knockdown cells to confirm specificity. The high conservation of Dom34 across species means some antibodies may cross-react with orthologs.
Epitope accessibility: Dom34's interactions with ribosomes and other proteins may mask epitopes. Different fixation or extraction methods may be required depending on the application.
Detection conditions: Dom34 often functions in complex with other proteins (Hbs1, RNase L), so optimization of IP conditions is important to preserve these interactions.
Subcellular localization: While primarily cytoplasmic, Dom34 can transiently associate with stress granules or P-bodies under specific conditions, affecting detection patterns.
For immunoprecipitation studies specifically targeting Dom34's role in antiviral defense, researchers should consider RNase treatment controls to distinguish RNA-dependent from direct protein interactions with RNase L.
Inconsistencies in Dom34 loss-of-function studies have been reported in the literature. For example, some studies found minimal growth defects in dom34 mutants, while others reported significant impairments . Several factors may contribute to these discrepancies:
Genetic background effects: The importance of Dom34 becomes more apparent in strains with compromised ribosome biogenesis or function. Researchers should carefully document the genetic background used.
Stress conditions: Dom34's functions are particularly important during and after stress. Standard laboratory growth conditions may not reveal phenotypes that become evident under:
Nutrient limitation (especially glucose starvation)
Translation stress (amino acid limitation)
Heat shock or oxidative stress
Viral infection
Compensatory mechanisms: Long-term depletion of Dom34 may lead to adaptation through upregulation of parallel pathways. Inducible or acute depletion systems can help avoid this issue.
Partial redundancy: Some functions of Dom34 may be partially compensated by other factors. Combining Dom34 depletion with knockdown of related factors may reveal synthetic phenotypes.
When troubleshooting inconsistent results, researchers should systematically vary stress conditions and examine acute versus chronic Dom34 depletion effects.
When investigating Dom34's function in antiviral defense, several critical controls should be included:
RNase L dependence: Tests in RNase L-deficient backgrounds to confirm the pathway specificity.
Rescue experiments: Reintroduction of wild-type Dom34 should restore antiviral activity, while functionally important mutants should not.
OAS activation control: 2-5A measurement or OAS activity assays to ensure the upstream pathway is functioning.
Translation dependence: Experiments with translation inhibitors to confirm that Dom34's antiviral effect requires active translation.
RNA specificity controls: Comparison of Dom34's effects on viral RNA versus endogenous cellular RNAs to demonstrate selective targeting.
Direct binding validation: Controls confirming physical interaction between Dom34 and RNase L, such as reciprocal co-immunoprecipitation or proximity ligation assays .
These controls help establish that Dom34's antiviral effect operates specifically through the OAS/RNase L pathway rather than through its general roles in translation or mRNA quality control.
Given Dom34's fundamental roles in translation and RNA quality control, several promising research directions relate to human disease:
Viral pathogenesis: Further characterization of how Dom34 (Pelota in humans) recognizes viral RNAs and how viruses might evade this surveillance.
Neurodegenerative disorders: Many neurodegenerative diseases involve ribosome stalling and protein aggregation. Dom34's role in resolving stalled ribosomes makes it a potential factor in these conditions.
Cancer biology: Translational dysregulation is a hallmark of many cancers. Dom34's role in controlling ribosome availability and stress recovery may have implications for cancer cell survival under nutrient-limited conditions.
Stress response pathways: Dom34's role in translational recovery after stress connects it to cellular resilience mechanisms relevant to aging and age-related diseases.
Each of these areas represents an opportunity to translate fundamental knowledge about Dom34 functions into potentially therapeutic applications, particularly in antiviral strategies that might enhance Dom34-mediated viral RNA degradation.
Several emerging technologies and methodological approaches would significantly advance Dom34 research:
Structural studies: Cryo-EM structures of Dom34 in complex with RNase L would provide insights into the mechanism of selective RNA targeting.
Single-molecule techniques: Real-time observation of Dom34-mediated ribosome recycling or mRNA degradation would clarify the kinetics and order of events.
Selective ribosome profiling: Methods that specifically capture ribosomes bound by Dom34 would reveal the full spectrum of its endogenous substrates.
Tissue-specific knockout models: Conditional Dom34/Pelota deletion in specific tissues would help understand its role in organismal physiology beyond cell culture.
Systems biology approaches: Integration of transcriptomics, proteomics, and ribosome profiling in Dom34-deficient cells under various stresses would provide a comprehensive view of its cellular functions.
These technological advances would help resolve current questions about how Dom34 recognizes its substrates and how its multiple functions are coordinated in different cellular contexts.